Research at the University of Colorado Anschutz Medical Campus could expand the reach and enhance the effectiveness of deep brain stimulation for Parkinson’s disease through advanced, computerized techniques, potentially benefiting some of the 90,000 people diagnosed each year in this country with the progressive movement disorder that has no cure.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
A new study from the University of Colorado Anschutz Medical Campus has upended decades of neuroscience dogma, revealing that dopamine, a neurotransmitter critical for movement, motivation, learning and mood, communicates in the brain with extraordinary […]
Veteran entrepreneur and molecular medical geneticist appointed as Transformative Biotech’s Co-CEO and Director BOULDER, Colo., May 15, 2024 /PRNewswire/ — Transformative Biotech, LLC (T-Bio), a molecular diagnostics technology company, today announced the appointment of Dr. […]
BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, today announced that new 2-month interim data from the ARCH open label […]
Copyright © 2026 Biotech Networks
